We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
-$3.24B
Cap. Flow %
-2.83%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.17%
2 Technology 17.03%
3 Consumer Discretionary 9.51%
4 Healthcare 5.77%
5 Financials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FA icon
2501
First Advantage
FA
$3.58B
$2.05M ﹤0.01%
123,841
+54,572
+79% +$798K
PLNT icon
2502
CALL
Planet Fitness
PLNT
$3.97B
$2.05M ﹤0.01%
28,100
VAL icon
2503
PUT
Valaris
VAL
$5.85B
$2.05M ﹤0.01%
+29,900
New +$2.05M
REPL icon
2504
Replimune Group
REPL
$1.52B
$2.05M ﹤0.01%
243,006
+162,303
+201% +$1.88M
XPER icon
2505
Xperi
XPER
$299M
$2.04M ﹤0.01%
185,533
+101,495
+121% +$979K
PRCH icon
2506
Porch Group
PRCH
$1.96B
$2.04M ﹤0.01%
663,462
+645,108
+3,515% +$907K
PZZA icon
2507
PUT
Papa John's
PZZA
$761M
$2.04M ﹤0.01%
26,800
-50,000
-65% -$3.4M
ACRS icon
2508
Aclaris Therapeutics
ACRS
$919M
$2.04M ﹤0.01%
1,939,010
+1,873,000
+2,837% +$5.71M
SITC icon
2509
SITE Centers
SITC
$157M
$2.04M ﹤0.01%
191,446
-12,292
-6% -$123K
EMBJ
2510
CALL
Embraer S.A. ADS
EMBJ
$13.5B
$2.03M ﹤0.01%
+110,000
New +$1.76M
ANSCU
2511
DELISTED
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
$2.03M ﹤0.01%
+200,000
New +$2.02M
CCS icon
2512
Century Communities
CCS
$1.97B
$2.03M ﹤0.01%
22,260
-38,406
-63% -$2.74M
MNDY icon
2513
CALL
monday.com
MNDY
$4.12B
$2.03M ﹤0.01%
10,800
+1,400
+15% +$225K
DUK icon
2514
CALL
Duke Energy
DUK
$94.3B
$2.02M ﹤0.01%
20,800
-19,300
-48% -$1.76M
GPMT
2515
Granite Point Mortgage Trust
GPMT
$50.1M
$2.02M ﹤0.01%
339,256
+1,956
+0.6% +$9.85K
EMR icon
2516
CALL
Emerson Electric
EMR
$88.2B
$2.01M ﹤0.01%
+20,700
New +$1.9M
ALSA
2517
DELISTED
Alpha Star Acquisition Corp
ALSA
$2.01M ﹤0.01%
180,000
AES icon
2518
CALL
AES
AES
$10.5B
$2.01M ﹤0.01%
+104,500
New +$1.7M
MGA icon
2519
PUT
Magna International
MGA
$17.8B
$2.01M ﹤0.01%
34,000
-137,000
-80% -$7.39M
ESRT icon
2520
Empire State Realty Trust
ESRT
$810M
$2.01M ﹤0.01%
206,925
-184,233
-47% -$1.6M
FTRE icon
2521
Fortrea Holdings
FTRE
$1.82B
$2M ﹤0.01%
57,408
+41,213
+254% +$1.26M
MTCH icon
2522
Match Group
MTCH
$9.53B
$2M ﹤0.01%
54,668
-407,327
-88% -$13.8M
WMK icon
2523
Weis Markets
WMK
$1.73B
$1.99M ﹤0.01%
+31,131
New +$1.98M
BTI icon
2524
British American Tobacco
BTI
$121B
$1.99M ﹤0.01%
67,887
-302,292
-82% -$9.2M
MT icon
2525
PUT
ArcelorMittal
MT
$56.2B
$1.99M ﹤0.01%
70,000

Similar funds

David Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.

  • David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
  • David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • David Shaw opened 575 new positions and closed 527 in Q4 2023.
  • David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.